NextPoint Therapeutics names Dr. Leena Gandhi chief medical officer

Leena Gandhi, MD, PhD, has been named chief medical officer of NextPoint Therapeutics, a biotechnology company focused on immuno-oncology through its work on the HHLA2 pathway.

Advertisement

Dr. Gandhi joins NextPoint from the Dana Farber Cancer Institute in Boston, according to a Feb. 21 news release. While at Dana Farber, she served as director of the Center for Cancer Therapeutic Innovation. 

Dr. Gandhi has also served as vice president of immuno-oncology development at pharmaceutical company Eli Lilly and director of thoracic medical oncology at New York University.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Chief Medical Officers

Advertisement

Comments are closed.